AsiaTIDES: Oligonucleotide & Peptide Therapeutics 2019

AsiaTIDES: Oligonucleotide & Peptide Therapeutics is organized by KNect365 Life Sciences and will be held from Feb 26 - 28, 2019 at Hilton Tokyo Bay, Tokyo, Kanto, Japan.

Description:
Register your team today and join 300 scientists and executives at our upcoming meeting, held February 26 - 28, 2019 in Tokyo.

AsiaTIDES 2019 keynote presentation lineup:

• The Discovery of Semaglutide – A Journey from Ala Scan to Structural Design of GLP-1 Analogues
- Jesper Lau, PhD.,Vice President, Protein and Peptide Chemistry at Novo Nordisk A/S

• New Strategies and Technologies in Oligonucleotide Therapeutic Development
- Thazha P. Prakash, PhD.,Director, Medicinal Chemistry at Ionis Pharmaceuticals

• The Chemistry behind Approved Oligonucleotide Therapeutics
- Muthiah (Mano) Manoharan, PhD., Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc.

• From Stereopurity to Precision Medicine: Optimizing the Properties of Antisense Nucleic Acid Therapeutics
- Chandra Vargeese, PhD., SVP, Head of Drug Discovery at WAVE Life Sciences

Speakers: Jesper Lau, PhD., Novo Dordisk A/S, Thazha P. Prakash, Ph.D., Ionis Pharmaceuticals , Muthiah (Mano) Manoharan, PhD., Alnylam Pharmaceuticals, Inc, Chandra Vargeese, PhD., WAVE Life Sciences

Time: 9:00 am - 5:00 pm

Additional details will be posted as soon as they are available.